Following up on the recommendations put forth by the Expert Management Panel on River Flood Mitigation, the Environmental and Safety Management (ESM) and Water Resources (WS) business units of the City of Calgary are currently assessing how to best develop a suite of watershed-scale climate models to capture various weather event scenarios that may affect the…

Some case reports on Quinolones, a potent and globally popular group of antibiotics that are used to treat a wide range of infections, have raised concern about their possible association with acute hepatic failure (AHF). Data from the US FDA Adverse Event Reporting System were evaluated for signals of AHF in association with systemically administered…

Risk Sciences International has launched The Global Risk Census. The goal of the Census is to provide insights into important risks that need to be confronted now and in the future. These insights will be of great value to decision-makers, policy-makers and indeed to all stakeholders affected by a myriad of local, regional or global…

Risk Sciences International (RSI) is pleased to announce in collaboration with the Ontario Centre for Climate Impacts and Adaptation Resources (OCCIAR), the public release of “Best Practices for Consideration of the Effects of Climate Change in Project-Level Assessments”.   The Best Practices document is available at RSI, CONTACT US HERE for a copy. The authoring team…

Adverse effects of drugs among the elderly should be given special attention when considering a pharmacological intervention. Two recent papers using large electronic health records have explored the impact of drugs with anticholinergic properties. The first, “Associations between Anticholinergic Burden and Adverse Health Outcomes in Parkinson Disease” view here used a HealthFacts database (Cerner Corporation, Kansas…

This issue of QuarterWatch analyzes MedWatch Reports from the third quarter of 2015. This issue identifies major differences in reports of cancer associated with drugs for psoriasis, a common skin disorder affecting an estimated 7.5 million people. While corticosteroid and other topical drugs are sufficient for many cases, potent immunosuppressant drugs are used in increasing…

The Center for Alternatives to Animal Testing and the Animal-Free Safety Assessment recently held their annual meeting on advancing toxicity testing in the 21st century (TT21C). This informal event provided brief updates on cutting edge approaches in toxicology that have accrued since the publication of the 2007 U.S. National Research Council report on Toxicity Testing…

RSI is pleased to be the recipient of funding through the DND IDEaS COVID-19 Challenge. Under the supervision of Emma Hartnett, RSI will be developing a risk-based tool to support public health emergency response planning for COVID-19, and other infectious disease and mass casualty emergencies in the future. The safety and well-being of Canadians are…

RSI and Engineers Canada are partnering to offer an online version of the introductory workshop on the PIEVC Protocol for infrastructure climate risk and vulnerability assessment. Online Workshop: Integrating Climate Risk into Infrastructure Development: The PIEVC Protocol April 2, 4, 9, 11, and 16, 2019;  11:30 a.m. to 1:30 p.m. EST This workshop  will provide participants…

RSI is pleased to announce that Norman Shippee recently joined the team as a Climate and Applications Specialist. Dr. Shippee earned his PhD at the University of Victoria. He is an experienced researcher who has focused on establishing stakeholder-defined storm metrics to facilitate safe operations in the marine transportation field. Dr. Shippee has previously provided…